Literature DB >> 24282281

Defective TGF-β signaling in bone marrow-derived cells prevents hedgehog-induced skin tumors.

Qipeng Fan1, Dongsheng Gu1, Hailan Liu1, Ling Yang1, Xiaoli Zhang1, Mervin C Yoder1, Mark H Kaplan1, Jingwu Xie1.   

Abstract

Hedgehog signaling in cancer cells drives changes in the tumor microenvironment that are incompletely understood. Here, we report that hedgehog-driven tumors exhibit an increase in myeloid-derived suppressor cells (MDSC) and a decrease in T cells, indicative of an immunosuppressive tumor microenvironment. This change was associated with activated TGF-β signaling in several cell types in basal cell carcinomas. We determined that TGF-β signaling in bone marrow-derived cells, not keratinocytes, regulates MDSC and promotes tumor development. Tgfbr2 deficiency in the bone marrow-derived cells also reduced the size of previously developed tumors in mice. We identified CCL2 as the major chemokine attracting MDSCs to tumor, whose expression was Tgfbr2-dependent, whereas its receptor CCR2 was highly expressed in MDSC population. CCL2 alone was sufficient to induce migration of MDSCs. Moreover, the CCR2 inhibitors prevented MDSC migration toward skin cells in vitro, and reduced MDSC accumulation and hedgehog signaling-driven tumor development in mice. Our results reveal a signaling network critical for hedgehog signaling in cancer cells to establish an effective immunosuppressive microenvironment during tumor development.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24282281      PMCID: PMC3963525          DOI: 10.1158/0008-5472.CAN-13-2134-T

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  45 in total

1.  Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle.

Authors:  T Mirzadegan; F Diehl; B Ebi; S Bhakta; I Polsky; D McCarley; M Mulkins; G S Weatherhead; J M Lapierre; J Dankwardt; D Morgans; R Wilhelm; K Jarnagin
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

2.  TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma.

Authors:  Pengyuan Yang; Qi-Jing Li; Yuxiong Feng; Yun Zhang; Geoffrey J Markowitz; Shanglei Ning; Yuezhen Deng; Jiangsha Zhao; Shan Jiang; Yunfei Yuan; Hong-Yang Wang; Shu-Qun Cheng; Dong Xie; Xiao-Fan Wang
Journal:  Cancer Cell       Date:  2012-09-11       Impact factor: 31.743

3.  A role for transcription factor STAT3 signaling in oncogene smoothened-driven carcinogenesis.

Authors:  Dongsheng Gu; Qipeng Fan; Xiaoli Zhang; Jingwu Xie
Journal:  J Biol Chem       Date:  2012-09-19       Impact factor: 5.157

Review 4.  TGFβ signalling in context.

Authors:  Joan Massagué
Journal:  Nat Rev Mol Cell Biol       Date:  2012-09-20       Impact factor: 94.444

5.  Deletion of TGF-β signaling in myeloid cells enhances their anti-tumorigenic properties.

Authors:  Sergey V Novitskiy; Michael W Pickup; Anna Chytil; Dina Polosukhina; Philip Owens; Harold L Moses
Journal:  J Leukoc Biol       Date:  2012-06-08       Impact factor: 4.962

6.  CXCR4-targeted therapy inhibits VEGF expression and chondrosarcoma angiogenesis and metastasis.

Authors:  Xiaojuan Sun; Cherie Charbonneau; Lei Wei; Wentian Yang; Qian Chen; Richard M Terek
Journal:  Mol Cancer Ther       Date:  2013-05-17       Impact factor: 6.261

Review 7.  History of myeloid-derived suppressor cells.

Authors:  James E Talmadge; Dmitry I Gabrilovich
Journal:  Nat Rev Cancer       Date:  2013-10       Impact factor: 60.716

8.  Suppression of vaccine immunity by inflammatory monocytes.

Authors:  Leah A Mitchell; Angela J Henderson; Steven W Dow
Journal:  J Immunol       Date:  2012-11-07       Impact factor: 5.422

9.  Smad3 binding to the foxp3 enhancer is dispensable for the development of regulatory T cells with the exception of the gut.

Authors:  Susan M Schlenner; Benno Weigmann; Qingguo Ruan; Youhai Chen; Harald von Boehmer
Journal:  J Exp Med       Date:  2012-08-20       Impact factor: 14.307

10.  Absence of signaling into CD4⁺ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3⁺ regulatory T cells.

Authors:  Michael G Strainic; Ethan M Shevach; Fengqi An; Feng Lin; M Edward Medof
Journal:  Nat Immunol       Date:  2012-12-23       Impact factor: 25.606

View more
  30 in total

1.  Bone marrow derived myeloid cells orchestrate antiangiogenic resistance in glioblastoma through coordinated molecular networks.

Authors:  B R Achyut; Adarsh Shankar; A S M Iskander; Roxan Ara; Kartik Angara; Peng Zeng; Robert A Knight; Alfonso G Scicli; Ali S Arbab
Journal:  Cancer Lett       Date:  2015-09-21       Impact factor: 8.679

2.  Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α.

Authors:  Yana G Najjar; Patricia Rayman; Xuefei Jia; Paul G Pavicic; Brian I Rini; Charles Tannenbaum; Jennifer Ko; Samuel Haywood; Peter Cohen; Thomas Hamilton; C Marcela Diaz-Montero; James Finke
Journal:  Clin Cancer Res       Date:  2016-10-31       Impact factor: 12.531

3.  Characterization of the myeloid-derived suppressor cell subset regulated by NK cells in malignant lymphoma.

Authors:  Yusuke Sato; Kanako Shimizu; Jun Shinga; Michihiro Hidaka; Fumio Kawano; Kazuhiro Kakimi; Satoru Yamasaki; Miki Asakura; Shin-Ichiro Fujii
Journal:  Oncoimmunology       Date:  2015-01-22       Impact factor: 8.110

Review 4.  Molecular pathways: myeloid complicity in cancer.

Authors:  Ingunn M Stromnes; Philip D Greenberg; Sunil R Hingorani
Journal:  Clin Cancer Res       Date:  2014-07-21       Impact factor: 12.531

Review 5.  Basal Cell Carcinoma and Hedgehog Pathway Inhibitors: Focus on Immune Response.

Authors:  Donatella Gambini; Emanuela Passoni; Gianluca Nazzaro; Giada Beltramini; Gianluca Tomasello; Michele Ghidini; Elisabetta Kuhn; Ornella Garrone
Journal:  Front Med (Lausanne)       Date:  2022-06-14

6.  Chimeric Mouse model to track the migration of bone marrow derived cells in glioblastoma following anti-angiogenic treatments.

Authors:  B R Achyut; Adarsh Shankar; A S M Iskander; Roxan Ara; Robert A Knight; Alfonso G Scicli; Ali S Arbab
Journal:  Cancer Biol Ther       Date:  2016-01-21       Impact factor: 4.742

7.  Combination of Asiatic Acid and Naringenin Modulates NK Cell Anti-cancer Immunity by Rebalancing Smad3/Smad7 Signaling.

Authors:  Guang-Yu Lian; Qing-Ming Wang; Patrick Ming-Kuen Tang; Shuang Zhou; Xiao-Ru Huang; Hui-Yao Lan
Journal:  Mol Ther       Date:  2018-06-22       Impact factor: 11.454

8.  Genetic Evidence for XPC-KRAS Interactions During Lung Cancer Development.

Authors:  Xiaoli Zhang; Nonggao He; Dongsheng Gu; Jeff Wickliffe; James Salazar; Istavan Boldogh; Jingwu Xie
Journal:  J Genet Genomics       Date:  2015-10-17       Impact factor: 4.275

Review 9.  The role of chemoattractant receptors in shaping the tumor microenvironment.

Authors:  Jiamin Zhou; Yi Xiang; Teizo Yoshimura; Keqiang Chen; Wanghua Gong; Jian Huang; Ye Zhou; Xiaohong Yao; Xiuwu Bian; Ji Ming Wang
Journal:  Biomed Res Int       Date:  2014-07-10       Impact factor: 3.411

10.  The hedgehog's trick for escaping immunosurveillance: The molecular mechanisms driving myeloid-derived suppressor cell recruitment in hedgehog signaling-dependent tumors.

Authors:  Jingwu Xie
Journal:  Oncoimmunology       Date:  2014-06-05       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.